These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 24062044)

  • 1. Optimal process mode selection for clone screening.
    Strnad J; Spudić V; Brinc M; Pungerčar JR; Kravanja Z
    Acta Chim Slov; 2011 Jun; 58(2):333-41. PubMed ID: 24062044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the transferability of membrane-based fed-batch shake flask cultivations to stirred-tank reactor using three different protease producing Bacillus strains.
    Müller J; Hütterott A; Habicher T; Mußmann N; Büchs J
    J Biosci Bioeng; 2019 Nov; 128(5):599-605. PubMed ID: 31151898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A strategy for clone selection under different production conditions.
    Legmann R; Benoit B; Fedechko RW; Deppeler CL; Srinivasan S; Robins RH; McCormick EL; Ferrick DA; Rodgers ST; Russo AP
    Biotechnol Prog; 2011; 27(3):757-65. PubMed ID: 21448991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic evaluation of characteristics of the membrane-based fed-batch shake flask.
    Philip P; Meier K; Kern D; Goldmanns J; Stockmeier F; Bähr C; Büchs J
    Microb Cell Fact; 2017 Jul; 16(1):122. PubMed ID: 28716035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fed-batch mode in shake flasks by slow-release technique.
    Jeude M; Dittrich B; Niederschulte H; Anderlei T; Knocke C; Klee D; Büchs J
    Biotechnol Bioeng; 2006 Oct; 95(3):433-45. PubMed ID: 16736531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for optimal protease producing Bacillus licheniformis strains with polymer-based controlled-release fed-batch microtiter plates.
    Habicher T; Klein T; Becker J; Daub A; Büchs J
    Microb Cell Fact; 2021 Feb; 20(1):51. PubMed ID: 33622330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Equalizing growth in high-throughput small scale cultivations via precultures operated in fed-batch mode.
    Huber R; Scheidle M; Dittrich B; Klee D; Büchs J
    Biotechnol Bioeng; 2009 Aug; 103(6):1095-102. PubMed ID: 19415772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening and assessment of performance and molecule quality attributes of industrial cell lines across different fed-batch systems.
    Rouiller Y; Bielser JM; Brühlmann D; Jordan M; Broly H; Stettler M
    Biotechnol Prog; 2016; 32(1):160-70. PubMed ID: 26489036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-throughput screening of Hansenula polymorpha clones in the batch compared with the controlled-release fed-batch mode on a small scale.
    Scheidle M; Jeude M; Dittrich B; Denter S; Kensy F; Suckow M; Klee D; Büchs J
    FEMS Yeast Res; 2010 Feb; 10(1):83-92. PubMed ID: 19849718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fed-batch bioreactor performance and cell line stability evaluation of the artificial chromosome expression technology expressing an IgG1 in Chinese hamster ovary cells.
    Combs RG; Yu E; Roe S; Piatchek MB; Jones HL; Mott J; Kennard ML; Goosney DL; Monteith D
    Biotechnol Prog; 2011; 27(1):201-8. PubMed ID: 21312367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel approach of high cell density recombinant bioprocess development: optimisation and scale-up from microliter to pilot scales while maintaining the fed-batch cultivation mode of E. coli cultures.
    Siurkus J; Panula-Perälä J; Horn U; Kraft M; Rimseliene R; Neubauer P
    Microb Cell Fact; 2010 May; 9():35. PubMed ID: 20487563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scale-up from shake flasks to fermenters in batch and continuous mode with Corynebacterium glutamicum on lactic acid based on oxygen transfer and pH.
    Seletzky JM; Noak U; Fricke J; Welk E; Eberhard W; Knocke C; Büchs J
    Biotechnol Bioeng; 2007 Nov; 98(4):800-11. PubMed ID: 17318907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conversion of a CHO cell culture process from perfusion to fed-batch technology without altering product quality.
    Meuwly F; Weber U; Ziegler T; Gervais A; Mastrangeli R; Crisci C; Rossi M; Bernard A; von Stockar U; Kadouri A
    J Biotechnol; 2006 May; 123(1):106-16. PubMed ID: 16324762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of a mammalian cell culture process by adaptive, model-based dialysis fed-batch cultivation and suppression of apoptosis.
    Frahm B; Lane P; Märkl H; Pörtner R
    Bioprocess Biosyst Eng; 2003 Nov; 26(1):1-10. PubMed ID: 14505167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel micro-bioreactor high throughput technology for cell culture process development: Reproducibility and scalability assessment of fed-batch CHO cultures.
    Amanullah A; Otero JM; Mikola M; Hsu A; Zhang J; Aunins J; Schreyer HB; Hope JA; Russo AP
    Biotechnol Bioeng; 2010 May; 106(1):57-67. PubMed ID: 20073088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose-limited high cell density cultivations from small to pilot plant scale using an enzyme-controlled glucose delivery system.
    Glazyrina J; Krause M; Junne S; Glauche F; Storm D; Neubauer P
    N Biotechnol; 2012 Jan; 29(2):235-42. PubMed ID: 22100433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein-free fed-batch culture of non-GS NS0 cell lines for production of recombinant antibodies.
    Burky JE; Wesson MC; Young A; Farnsworth S; Dionne B; Zhu Y; Hartman TE; Qu L; Zhou W; Sauer PW
    Biotechnol Bioeng; 2007 Feb; 96(2):281-93. PubMed ID: 16933323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the behavior of CHO cells during cultivation in 24-square deep well microplates and conventional shake flask systems.
    Chaturvedi K; Sun SY; O'Brien T; Liu YJ; Brooks JW
    Biotechnol Rep (Amst); 2014 Jun; 1-2():22-26. PubMed ID: 28435799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Derivation and characterization of cholesterol-independent non-GS NS0 cell lines for production of recombinant antibodies.
    Hartman TE; Sar N; Genereux K; Barritt DS; He Y; Burky JE; Wesson MC; Tso JY; Tsurushita N; Zhou W; Sauer PW
    Biotechnol Bioeng; 2007 Feb; 96(2):294-306. PubMed ID: 16897745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibody process development using medium concentrates.
    Bibila TA; Ranucci CS; Glazomitsky K; Buckland BC; Aunins JG
    Biotechnol Prog; 1994; 10(1):87-96. PubMed ID: 7764531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.